Energy Regulation Mechanism and Therapeutic Potential of Asprosin
Open accessThe DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Genetic studies of patients with neonatal progeroid syndrome led to the discovery of the novel fasting-induced, glucogenic, and orexigenic hormone named asprosin, the C-terminal cleavage product of profibrillin. Upon secretion, asprosin travels to the liver, where it exerts a glucogenic effect through OR4M1, an olfactory G-protein–coupled receptor. It also crosses the blood-brain barrier to stimulate appetite-modulating neurons in the arcuate nucleus of the hypothalamus, exerting an orexigenic effect via an as yet unidentified receptor. Specifically, it stimulates appetite by activating orexigenic AgRP neurons and inhibiting anorexigenic POMC neurons. Studies have also focused on the therapeutic potential of inhibiting asprosin for treatment of obesity and type 2 diabetes, both of which are characterized by high levels of circulating asprosin. It has been shown that anti-asprosin monoclonal antibodies reduce blood glucose, appetite, and body weight, validating asprosin as a therapeutic target. Current work aims to uncover key features of the asprosin biology such as the identification of its neuronal receptor, identification of the secretion mechanism from adipose tissue, and development of anti-asprosin monoclonal antibodies as diabetes and obesity therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Anti-asprosin monoclonal antibodies reduce blood glucose, appetite, and body weight [183].”
From Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 (2022) · cites this paper as [183]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for ghrelin in the central regulation of feeding
Nakazato, M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kangawa, K., & Matsukura, S. (2001) · Nature · doi:10.1038/35051587 · Cited by 3,443 · cited 1×
“Interestingly, it took several hours after injection before the increase in food intake occurred, differentiating asprosin from the acutely acting hormone ghrelin (26).”
BackgroundThe role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review
Klok, M. D., Jakobsdottir, S., & Drent, M. L. (2007) · Obesity Reviews · doi:10.1111/j.1467-789x.2006.00270.x · Cited by 1,442 · cited 1×
“Leptin, an anorexigenic hormone secreted from white adipose tissue, also regulates energy balance through modulation of AgRP and POMC neurons (27).”
BackgroundMechanisms of insulin resistance in obesity
Ye, J. (2013) · Frontiers of Medicine · doi:10.1007/s11684-013-0262-6 · Cited by 699 · cited 1×
“Additionally, the vast majority of patients with obesity also manifest with insulin resistance (35).”
BackgroundAsprosin, a Fasting-Induced Glucogenic Protein Hormone
Romere, C., Duerrschmid, C., Bournat, J., Constable, P., Jain, M., Xia, F., Saha, P. K., Del Solar, M., Zhu, B., York, B., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.063 · Cited by 591 · cited 10×
“While FBN1 is expressed in many tissues, its highest expression in both humans and mice is inwhite adipose (1).”
BackgroundSelf-citationAsprosin is a centrally acting orexigenic hormone
Duerrschmid, C., He, Y., Wang, C., Li, C., Bournat, J. C., Romere, C., Saha, P. K., Lee, M. E., Phillips, K. J., Jain, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4432 · Cited by 357 · cited 10×
“Fbn1 mice were created using CRISPR/ Cas9 to induce a frame shift leading to the deletion of the asprosin-coding region (9).”
BackgroundMethodSelf-citationCell type-specific transcriptomics of hypothalamic energy-sensing neuron responses to weight-loss
Henry, F. E., Sugino, K., Tozer, A., Branco, T., & Sternson, S. M. (2015) · eLife · doi:10.7554/elife.09800 · Cited by 240 · cited 1×
“Comprehensive gene expression profiles did not show Olfr734 expression in AgRP or POMC neurons in mice in either the fasted or fed state (25).”
BackgroundOLFR734 Mediates Glucose Metabolism as a Receptor of Asprosin
Li, E., Shan, H., Chen, L., Long, A., Zhang, Y., Liu, Y., Jia, L., Wei, F., Han, J., Li, T., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.05.022 · Cited by 221 · cited 20×
“They also had reduced cAMP levels, decreased hepatic glucose release, and improved insulin sensitivity (as measured by insulin tolerance test, hyperinsulimic-euglycemic clamp, and glucose tolerance test) compared with wild-type mice (22).”
BackgroundMethodResultInfluentialWang, Y., Qu, H., Xiong, X., Qiu, Y., Liao, Y., Chen, Y., Zheng, Y., & Zheng, H. (2018) · Mediators of Inflammation · doi:10.1155/2018/9471583 · Cited by 189 · cited 3×
“The authors also showed that plasma asprosin concentration is positively correlated with patient waist circumference, fasting plasma glucose, HbA1c, triglycerides, impaired glucose regulation, type 2 diabetes, and HOMA for insulin resistance (19).”
BackgroundInfluentialLee, T., Yun, S., Jeong, J. H., & Jung, T. W. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.03.001 · Cited by 188 · cited 1×
“(16) found that MIN6 pancreatic b-cells and human primary islets containing b-cells secrete asprosin and that secretion is induced by palmitate in a dosedependent manner.”
BackgroundZhang, L., Chen, C., Zhou, N., Fu, Y., & Cheng, X. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.10.034 · Cited by 182 · cited 3×
“While serum asprosin was positively associated with adiposity-related parameters such as BMI, waist circumference, and waist-to-hip ratio in patients with type 2 diabetes, these adiposity markers were not independently associated with asprosin concentrations (18).”
BackgroundInfluentialSaliva and Blood Asprosin Hormone Concentration Associated with Obesity
Uğur, K., & Aydın, S. (2019) · International Journal of Endocrinology · doi:10.1155/2019/2521096 · Cited by 166 · cited 3×
“Immunohistochemistry showed the presence of asprosin in the interlobular striated ducts and interlobular ducts of submandibular and parotid glands (17).”
BackgroundInfluentialLi, X., Liao, M., Shen, R., Zhang, L., Hu, H., Wu, J., Wang, X., Qu, H., Guo, S., Long, M., et al. (2018) · Mediators of Inflammation · doi:10.1155/2018/7375294 · Cited by 159 · cited 1×
“Plasma asprosin levels are associated with glucose metabolism, lipid, and sex hormone profiles in females with metabolic related diseases (21) Asprosin is higher in patients with PCOS compared with healthy female patients but still lower than female patients with type 2 diabetes.”
BackgroundAlan, M., Gürlek, B., Yılmaz, A., Akşit, M., Aslanıpour, B., Gülhan, İ., Çalan, M., & Taner, C. E. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1512967 · Cited by 156 · cited 2×
“Similar to patients with freestanding obesity or diabetes, patients with PCOS had higher levels of circulating asprosin compared with control subjects and plasma asprosin levels were positively correlated with insulin resistance, BMI, and free androgen index (20).”
BackgroundAutonomic Nervous System and the Liver
Mizuno, K., & Ueno, Y. (2017) · Hepatology Research · doi:10.1111/hepr.12760 · Cited by 137 · cited 1×
“Potential ways this could occur is through modulation of sympathetic or parasympathetic drive at the level of the liver and also other organs known to be important for glucose homeostasis (29).”
BackgroundSerum asprosin levels and bariatric surgery outcomes in obese adults
Wang, C., Lin, T., Liu, K., Liao, C., Liu, Y.-Y., Wu, V. C., Wen, M., & Yeh, T. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0248-1 · Cited by 135 · cited 4×
“Recently, it has been shown in a study of 117 obese patients that the amount of circulating asprosin pre–bariatric surgery is directly related to the amount of weight loss seen 6 months after surgery (33).”
BackgroundInfluentialWang, M., Yin, C., Wang, L., Liu, Y., Li, H., Li, M., Yi, X., & Xiao, Y. (2019) · Annals of Nutrition and Metabolism · doi:10.1159/000503808 · Cited by 104
Raghunath, M., Putnam, E. A., Ritty, T., Hamstra, D., Park, E.-S., Tschödrich-Rotter, M., Peters, R., Rehemtulla, A., & Milewicz, D. M. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.7.1093 · Cited by 95
Growth and maturation in Marfan syndrome
Erkula, G., Jones, K. B., Sponseller, P. D., Dietz, H. C., & Pyeritz, R. E. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10312 · Cited by 94 · cited 1×
“Given that NPS patients are 3–5 standard deviations leaner than patients with Marfan syndrome (8) and display robust insulin sensitivity despite partial lipodystrophy, Romere et al.”
BackgroundDecreased Circulating Levels of Asprosin in Obese Children
Long, W., Xie, X., Du, C., Zhao, Y., Zhang, C., Zhan, D., Li, Z., Ning, Q., & Luo, X. (2019) · Hormone Research in Paediatrics · doi:10.1159/000500523 · Cited by 93 · cited 2×
“Decreased circulating levels of asprosin in obese children (30) Fasting asprosin levels were lower in obese children than in normal weight children.”
BackgroundWiecek, M., Szymura, J., Maciejczyk, M., Kantorowicz, M., & Szygula, Z. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01782 · Cited by 85 · cited 1×
“Acute anaerobic exercise affects the secretion of asprosin, irisin, and other cytokines – a comparison between sexes (37) Acute anaerobic exercise induced an increase in asprosin secretion in women.”
BackgroundGraul‐Neumann, L. M., Kienitz, T., Robinson, P. N., Baasanjav, S., Karow, B., Gillessen‐Kaesbach, G., Fahsold, R., Schmidt, H., Hoffmann, K., & Passarge, E. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33690 · Cited by 83
Making sense of the sensory regulation of hunger neurons
Chen, Y., & Knight, Z. A. (2016) · BioEssays · doi:10.1002/bies.201500167 · Cited by 82 · cited 1×
“arcuate nucleus of the hypothalamus (24).”
Processing of the Fibrillin-1 Carboxyl-terminal Domain
Ritty, T. M., Broekelmann, T. J., Tisdale, C., Milewicz, D. M., & Mecham, R. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8933 · Cited by 82 · cited 1×
“While the specific cellular location of profibrillin cleavage is largely unknown, it is speculated to occur between the trans-Golgi network and the cell surface, or upon fibrillin-1 secretion (13,14).”
BackgroundAdvances in the understanding of adipose tissue biology
Kajimura, S. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.211 · Cited by 79 · cited 1×
“Evidence suggests that asprosin is secreted from white adipose tissue, which accounts for 5–50% of human body weight and is already known to secrete adipokines such as leptin and adiponectin (15).”
BackgroundDevelopment of Hypothalamic Circuits That Control Food Intake and Energy Balance
Bouret, S. G. (2017) · CRC Press eBooks · doi:10.1201/9781315120171-7 · Cited by 78 · cited 1×
“AgRP and POMC neurons project into other parts of the hypothalamus including the paraventricular nucleus, lateral hypothalamic area, and the dorsomedial nucleus, which in turn project to intrahypothalamic and extrahypothalamic regions to regulate feeding and other processes (28).”
BackgroundIncreased serum circulating asprosin levels in children with obesity
Silistre, E. S., & Hatipoğlu, H. U. (2020) · Pediatrics International · doi:10.1111/ped.14176 · Cited by 75 · cited 2×
“However, two additional studies have shown that plasma asprosin levels are significantly elevated in obese children compared to normal weight subjects (31,32).”
BackgroundLonnqvist, L. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.13.2039 · Cited by 65 · cited 3×
“Profibrillin is cleaved by the calcium dependent furin/PACE (paired basic amino acid cleaving enzyme) serine endoprotease, which is part of the subtilisin family (11,12).”
BackgroundTakenouchi, T., Hida, M., Sakamoto, Y., Torii, C., Kosaki, R., Takahashi, T., & Kosaki, K. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36157 · Cited by 60
Jacquinet, A., Verloès, A., Callewaert, B. L., Coremans, C., Coucke, P. J., Paepe, A. D., Kornak, U., Lebrun, F., Lombet, J., Pierard, G., et al. (2014) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2014.02.012 · Cited by 51
Acara, A. Ç., Bolatkale, M., Kızıloğlu, İ., İbişoğlu, E., & Can, Ç. (2017) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2017.12.032 · Cited by 50 · cited 1×
“A novel biochemical marker for predicting the severity of ACS with unstable angina pectoris: asprosin (39) Asprosin is a marker for unstable angina pectoris and the severity of acute coronary syndrome.”
BackgroundHorn, D., & Robinson, P. N. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33905 · Cited by 47
An Overall Comparison of Small Molecules and Large Biologics in ADME Testing
Wan, H. (2016) · ADMET & DMPK · doi:10.5599/admet.4.1.276 · Cited by 47 · cited 1×
“The immunologic approach has two benefits: using a monoclonal antibody to inhibit asprosin has already displayed proof-of-concept in mice, and monoclonal antibodies in general tend to be more specific with fewer off-target effects than small molecule therapies (36).”
BackgroundWallis, D. D., Putnam, E. A., Cretoiu, J. S., Carmical, S. G., Cao, S., Thomas, G., & Milewicz, D. M. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10657 · Cited by 46 · cited 1×
“While the specific cellular location of profibrillin cleavage is largely unknown, it is speculated to occur between the trans-Golgi network and the cell surface, or upon fibrillin-1 secretion (13,14).”
BackgroundGoldblatt, J., Hyatt, J., Edwards, C., & Walpole, I. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33906 · Cited by 43
Baykuş, Y., Yavuzkır, Ş., Üstebay, S., Uğur, K., Deniz, R., & Aydın, S. (2019) · Peptides · doi:10.1016/j.peptides.2019.170132 · Cited by 43 · cited 1×
“Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and macrosemic fetus (38) Pregnant women with gestational diabetes mellitus, preeclampsia, severe preeclampsia, and macrosemic fetuses have significantly higher asprosin…”
BackgroundBody fat distribution and metabolic variables in patients with neonatal progeroid syndrome
O'Neill, B., Simha, V., Kotha, V., & Garg, A. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31840 · Cited by 40
Case Reports of Pre-clinical Replication Studies in Metabolism and Diabetes
von Herrath, M., Pagni, P. P., Grove, K., Christoffersson, G., Tang-Christensen, M., Karlsen, A. E., & Petersen, J. S. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.004 · Cited by 39 · cited 1×
“also provided an explanation for the difficulty we and others (23) have experienced using Histagged recombinant asprosin.”
BackgroundBeutler, L. R., & Knight, Z. A. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.050 · Cited by 27 · cited 1×
“Besides ghrelin, asprosin is one of the very few known orexigenic hormones, with the vast majority of known appetite-influencing hormones being anorexigenic (34).”
BackgroundChen, M., Yao, B., Yang, Q., Deng, J., Song, Y., Sui, T., Zhou, L., Yao, H., Xu, Y., Ouyang, H., et al. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.031542 · Cited by 27 · cited 2×
“In both species the result is a phenocopy of the human disorder, with significantly reduced body weight and adiposity (9,10).”
BackgroundIncreased plasma asprosin levels in patients with drug-naive anorexia nervosa
Hu, Y., Xu, Y., Zheng, Y., Kang, Q., Lou, Z., Liu, Q., Chen, H., Ji, Y., Guo, L., Chen, C., et al. (2020) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-020-00845-3 · Cited by 26 · cited 1×
“Increased plasma asprosin levels in patients with drug-naive anorexia nervosa (40) Elevated plasma asprosin concentration in patients with anorexia nervosa in response to starvation is associated with an interoceptive deficit.”
Background
Cited by
Mazur-Biały, A. I. (2021) · Nutrients · doi:10.3390/nu13020620 · Cited by 97
“Olfr734 is a mouse ortholog of human OR4M1 r ceptor [8].”
BackgroundInfluentialBays, H. E., Fitch, A., Christensen, S., Burridge, K., & Tondt, J. (2022) · Obesity Pillars · doi:10.1016/j.obpill.2022.100018 · Cited by 68
Old Paradoxes and New Opportunities for Appetite Control in Obesity
Montégut, L., López-Otín, C., Magnan, C., & Kroemer, G. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.02.005 · Cited by 48
Discovery of a possible role of asprosin in ovarian follicular function
Maylem, E. R. S., SPICER, L. J., Batalha, I. M., & Schütz, L. F. (2020) · Journal of Molecular Endocrinology · doi:10.1530/jme-20-0218 · Cited by 51
A Serum Marker for Early Pancreatic Cancer With a Possible Link to Diabetes
Nam, H., Hong, S., Jung, K. H., Kang, S., Park, M. S., Kang, S., Kim, H. S., Mai, V.-H., Kim, J., Lee, H., et al. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab191 · Cited by 38
Metadata
- Authors
- Hoffmann, J. G., Xie, W., & Chopra, A. R.
- Affiliations
- University Hospitals of Cleveland (US)
- Corresponding author
- Chopra, Atul R.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2020-03-16
- Volume
- 69
- Issue
- 4
- Pages
- 559-566
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC7085243
- OpenAlex
- W3011199148
- Cited by
- 52
- References
- 41
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 12 · 2023: 7 · 2022: 11 · 2021: 6 · 2020: 5
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- asprosin, blood-brain barrier, hypothalamic regulation of appetite, arcuate nucleus, AgRP neurons, POMC neurons, obesity, type 2 diabetes, adipose tissue secretion, energy regulation
- MeSH terms
- Fibrillin-1, Animals, Blood Glucose, Diabetes Mellitus, Type 2, Energy Metabolism, Humans, Microfilament Proteins, Obesity, Peptide Fragments, Peptide Hormones, Adipokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.